迪尔生物 (873831.OC)

+ 收藏

现金流量表(迪尔生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市前
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 96,583,382.59216,494,343.0999,444,842.65176,300,695.5273,302,748.96
 收到的税费返还(元) 775,789.60761,725.9426,581.48665,183.57128,264.91
 收到其他与经营活动有关的现金(元) 1,121,822.722,526,077.51439,043.961,569,468.8892,267.52
 经营活动现金流入小计(元) 98,480,994.91219,782,146.5499,910,468.09178,535,347.9773,523,281.39
 购买商品、接受劳务支付的现金(元) 46,186,638.0283,614,653.6942,912,253.0774,425,337.9026,420,033.68
 支付给职工以及为职工支付的现金(元) 30,263,039.0552,891,264.4128,905,685.2747,402,091.8626,310,581.72
 支付的各项税费(元) 5,493,382.0010,007,864.215,092,285.714,675,256.671,047,379.83
 支付其他与经营活动有关的现金(元) 12,859,472.5024,989,285.5312,161,705.1826,082,204.1110,438,701.25
 经营活动现金流出小计(元) 94,802,531.57171,503,067.8489,071,929.23152,584,890.5464,216,696.48
 经营活动产生的现金流量净额(元) 3,678,463.3448,279,078.7010,838,538.8625,950,457.439,306,584.91
二、投资活动产生的现金流量
 收回投资收到的现金(元) 68,000,000.00148,992,344.0979,000,000.00175,460,000.00132,460,000.00
 取得投资收益收到的现金(元) 1,417,961.67916,047.49516,090.301,110,449.29811,271.22
 收到其他与投资活动有关的现金(元) -14,142,950.08---
 投资活动现金流入小计(元) 69,417,961.67164,051,341.6679,516,090.30176,570,449.29133,271,271.22
 购建固定资产、无形资产和其他长期资产支付的现金(元) 6,158,398.8335,866,306.0416,444,199.3124,828,240.5212,501,378.83
 投资支付的现金(元) 60,000,000.00132,000,000.0050,000,000.00172,000,000.00102,000,000.00
 支付其他与投资活动有关的现金(元) ---14,142,950.08-
 投资活动现金流出小计(元) 66,158,398.83167,866,306.0466,444,199.31210,971,190.60114,501,378.83
 投资活动产生的现金流量净额(元) 3,259,562.84-3,814,964.3813,071,890.99-34,400,741.3118,769,892.39
三、筹资活动产生的现金流量
 吸收投资收到的现金(元) ---12,362,264.15-
 筹资活动现金流入小计(元) ---12,362,264.15-
 分配股利、利润或偿付利息支付的现金(元) -9,768,000.00---
 筹资活动现金流出小计(元) -9,768,000.00---
 筹资活动产生的现金流量净额(元) --9,768,000.00-12,362,264.15-
四、汇率变动对现金及现金等价物的影响(元) 429,971.66508,113.891,579,717.432,568,042.851,346,534.50
五、现金及现金等价物净增加额(元) 7,367,997.8435,204,228.2125,490,147.286,480,023.1229,423,011.80
 加:期初现金及现金等价物余额(元) 70,485,851.1035,281,622.8949,576,772.9728,801,599.7728,801,599.77
 期末现金及现金等价物余额(元) 77,853,848.9470,485,851.1075,066,920.2535,281,622.8958,224,611.57
补充资料:
 净利润(元) 19,201,490.7337,344,430.1918,109,730.9323,186,618.0610,913,352.44
 资产减值准备(元) 141,934.43953,364.5617,197.34343,455.5292,123.55
 固定资产和投资性房地产折旧(元) 2,334,459.644,653,373.711,934,490.024,648,143.772,394,393.04
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 2,334,459.644,653,373.711,934,490.024,648,143.772,394,393.04
 无形资产摊销(元) 250,749.84517,707.26257,204.88498,686.46247,770.90
 长期待摊费用摊销(元) 8,618.40----
 待摊费用的减少(元) -249,306.00----
 固定资产报废损失(元) 309.98--11,265.8710,022.38
 公允价值变动损失(元) -124,808.40-534,190.55-255,448.36-388,846.77-156,417.85
 财务费用(元) --508,113.89-1,411,534.40-1,871,117.47-940,636.75
 投资损失(元) -437,544.88-916,047.49-516,090.30-1,110,449.29-811,271.22
 递延所得税(元) -199.63-12,311.91103,903.71264,544.236,514.14
  其中:递延所得税资产减少(元) -199.63-12,311.91103,903.71264,544.236,514.14
 存货的减少(元) -4,863,563.29-6,520,133.12-3,468,370.67-8,931,714.85688,167.33
 经营性应收项目的减少(元) -3,258,079.32-378,163.78-1,417,815.95-2,249,781.92-2,822,003.99
 经营性应付项目的增加(元) -9,896,195.4613,679,163.72-3,114,961.1611,549,653.82-1,134,529.11
 其他(元) 221,071.42-710,120.66-909,252.76
 现金的期末余额(元) 77,853,848.9470,485,851.1075,066,920.2535,281,622.8958,224,611.57
 减:现金的期初余额(元) 70,485,851.1035,281,622.8949,576,772.9728,801,599.7728,801,599.77
 现金及现金等价物的净增加额(元) 7,367,997.8435,204,228.2125,490,147.286,480,023.1229,423,011.80
公告日期 2024-08-282024-04-262023-08-252023-04-142023-08-25
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院